Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of the study is to measure the impact on immune activation and inflammatory markers of switching from a triple combination antiretroviral therapy (cART) to a long acting dual therapy in HIV-infected patients
Epistemonikos ID: bc850d4ccb917c22ccc4c075c422f5f1e3dac269
First added on: May 13, 2024